Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel

Product Details
Customization: Available
Powder: Yes
Customized: Non-Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
  • Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
  • Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
  • Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
  • Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
  • Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
Find Similar Products
  • Overview
  • Product Description
  • Packaging & Shipping
  • Company Profile
Overview

Basic Info.

Model NO.
Docetaxel
Certification
GMP, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Solid
Purity
>99%
Transport Package
1kg Per Bag, 25kg Per Drum
Specification
99%
Trademark
Biohorlden
Origin
China
Production Capacity
50000kg/Month

Product Description

Product Description

 

 Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
Product Name: Docetaxel
CAS: 114977-28-5
MF: C43H53NO14
MW: 807.87922
EINECS: 601-339-2
Product Categories: Plant extracts;Herb extract;API;chemical reagent;pharmaceutical intermediate;phytochemical;-;Inhibitors;Pharmaceutical material and intermeidates;Taxotere;Active Pharmaceutical Ingredients;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;inhibitor;Antineoplastics;Antineoplastic;Anti-cancer&immunity
Molecular Structure:                                 Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel has an approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed.

Administered as a one-hour infusion every three weeks generally over a ten cycle course, docetaxel is considered better than doxorubicin, paclitaxel and fluorouracil as a cytotoxic antimicrotubule agent.
 
Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
Product Name
Alpha arbutin powder
Item of Test
Limits of Test
Results of Test
Appearance
White powder
White crystalline powder
Assay (HPLC)
≥99%
99.3%
Particle
100% pass 80 mesh
Conforms
Odor
Odorless
Conforms
Sulphated Ash
<0.5%
0.21%
Melting Point
195-196°C
195.2°C
PH Value Of 1% Aqueous Solution
5.0~7.0
5.2
Clarity Of Water Solution
Transparency, colorless, none suspended matters
Conforms
Heavy Metals
<10%
Conforms
As
<1.0ppm
Conforms
Pb
<3.0ppm
Conforms
Cd
<0.05ppm
Conforms
Hg
≤0.1mg/kg
Conforms
Loss on drying
<0.5%
0.35%
Total Plate Count
<1000cfu/g
95cfu/g
Yeast & Mold
<100cfu/g
33 cfu/g
E.Coli
Negative
Absent
S. Aureus
Negative
Absent
Salmonella
Negative
Absent
Pesticides
Negative
Absent
Conclusion
Conform with specification
Storage
Store in 2-8°C, cool & dry place, Keep away from strong light and heat.
Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel1.It is a clinically well established anti mitotic chemotherapy medication (that is, it interferes with cell division).

2.It is used mainly for the treatment of breast, ovarian, and non-small cell lung cancer.

3.It has an FDA approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline based  chemotherapy and failed to stop cancer progression or relapsed. An European  approval  docetaxel for use in hormone-refractory prostate cancer.

4.It is considered better than doxorubicin, paclitaxel and fluorouracil as a cytotoxic antimicrotubule.
Packaging & Shipping

Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel

 

 

Company Profile

Xi'an Biohorlden Industry&Trade Co.,Ltd is a national key high-tech enterprise,which mainly specializes in the R&D, operation and production of pharmaceuticals,and intermediates.Our company is situated in E&T development zone,xi'an city shaanxi,it is easy of access. Our company has independent R&D center,raw material synthesis workshop, has advanced quality instruments and equipmentm,several product patents there are 15 experts in our research team.We insist in innovation and produce high quality products.

Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel


Anti-Cancer Intermediate 99% Docetaxel API Raw Material Powder CAS 114977-28-5 Docetaxel
1.Are you a manufacturer or trade company?
We are a professional manufacturer.
2.What's your payment terms?
Standard terms: T/T in advance and Western Union.
Also L/C at sight is acceptable for large amount.
3.What's your shipping time?
3-5 days
4.How do you ensure the quality of your products?
Strict QC with 6 steps testing from raw material purchase to finished product.
5.How do you ship the order normally?
By air, by sea. By express: DHL,FEDEX,UPS,TXT,EMS,and so on.
6.What's your loading port?
Usually Beijing, Shanghai, Qingdao, Tianjin, Guangzhou

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier